Remikiren 126222-34-2
Remikiren is a renin inhibitor under development for the treatment of hypertension (high blood pressure). It was first developed by Hoffmann–La Roche in 1996.
read more [+]| Systematic (IUPAC) name: | (2S)-2-[(2R)-2-benzyl-3-(2-methylpropane-2-sulfonyl)propanamido]-N-[(2R,3S,4R)-1-cyclohexyl-4-cyclopropyl-3,4-dihydroxybutan-2-yl]-3-(1H-imidazol-4-yl)propanamide |
|---|---|
| Remikiren CAS number: | 126222-34-2 |
| ATC code: | C09XA01 |
| PubChem: | 5462340 |
| DrugBank: | APRD00163 |
| Formula: | C33H50N4O6 |
| Molecular mass: | 630.839 g/mol |
| Remikiren Assay/Purity: | Typically NLT 98% |
